Skip to main content

Advertisement

Open Peer Review Reports for: Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
28 Aug 2008 Submitted Original manuscript
23 Sep 2008 Reviewed Reviewer Report - CARMEN BALAÑA
24 Sep 2008 Reviewed Reviewer Report - Antonio Silvani
14 Oct 2008 Reviewed Reviewer Report - Bernd Kaina
8 Nov 2008 Author responded Author comments - Alessandra Fabi
Resubmission - Version 2
8 Nov 2008 Submitted Manuscript version 2
17 Dec 2008 Reviewed Reviewer Report - CARMEN BALAÑA
Resubmission - Version 3
Submitted Manuscript version 3
12 Feb 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 4
12 Feb 2009 Submitted Manuscript version 4
7 Mar 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 5
7 Mar 2009 Submitted Manuscript version 5
30 Mar 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 6
30 Mar 2009 Submitted Manuscript version 6
Publishing
31 Mar 2009 Editorially accepted
31 Mar 2009 Article published 10.1186/1471-2407-9-101

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement